Ocular assessment of patients treated with tamoxifen
Beck, M.; Mills, P.V.
Cancer Treatment Reports 63(11-12): 1833-1834
1979
ISSN/ISBN: 0361-5960 PMID: 526917 Document Number: 151964
Tamoxifen is a specific estrogen antagonist used in the treatment of breast cancer. In a previous study, corneal and retinal changes were reported in four patients receiving high-dose tamoxifen therapy for greater than 1 year. Nineteen patients treated with tamoxifen for periods of 3 months to 4 years at normal dose levels have been studied and no ocular changes attributable to the drug were observed.
Document emailed within 1 workday
Related Documents
Le Bouëdec, G.; De Latour, M.; Feillel, V.; Dauplat, J. 1990: Metrorrhagia and tamoxifen. Apropos of 22 patients treated for cancer of the breast Journal de Gynecologie Obstetrique et Biologie de la Reproduction 19(7): 889-894Willèn, R.; Willèn, H.; Lindahl, B. 2002: Similarity of uterine mucosa changes in patients treated by raloxifen and tamoxifen Anticancer Research 22(2b): 1121-1125
Ivanova, V.; Karaivanov, M.; Marinov, E.; Gorchev, G.; Velkova, A.; Khristova, P. 2003: Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex) Akusherstvo i Ginekologiia 42(5): 3-8
Burke, P.; Fasciano, F.; Frigerio, A.; Temporelli, A.; Fortunati, N. 1987: Ultrasonic diagnostic studies of the post-menopausal uterus in patients treated with tamoxifen Minerva Ginecologica 39(6): 453-457
Wojtacki, J.; Dziewulska-Bokiniec, A. 1993: Level of total cholesterol in serum of patients with breast cancer treated with tamoxifen Polski Tygodnik Lekarski 48(23-24): 505-506
Baldini, B.; Taddei, G.L.; Tiso, E.; Visioli, C.B.; Campos, K.J.; Napolitano, A.C.; Tantini, C. 1996: Hysteroscopic evaluation of the endometrium in 63 postmenopausal patients treated with tamoxifen for breast cancer Minerva Ginecologica 48(6): 259-262
Valenzano, M.; Bertelli, G.F.; Costantini, S.; Corticelli, A.; Del Mastro, L.; Paoletti, R.; Garrone, O.; Rissone, R. 2001: Transvaginal ultrasonography and hysterosonography to monitor endometrial effects in tamoxifen-treated patients European Journal of Gynaecological Oncology 22(6): 441-444
Al-Alwan, N.A.; al-Kubaisy, W.; al-Rawaq, K. 2000: Assessment of response to tamoxifen among Iraqi patients with advanced breast cancer Eastern Mediterranean Health Journal 6(2-3): 475-482
Ivanova, V.; Karaivanov, M.; Raĭcheva, S.; Marinov, E.; Gorchev, G. 2004: Histological analysis of endometrial polyps in breast cancer patients treated with tamoxifen (nolvadex) Akusherstvo i Ginekologiia 43(2): 33-36
Bhatavdekar, J.M.; Shah, N.G.; Patel, D.D.; Karelia, N.H.; Trivedi, S.N.; Vora, H.H.; Ghosh, N.; Giri, D.D.; Balar, D.B. 1992: Endocrine function in premenopausal and postmenopausal advanced breast cancer patients treated with CMF or tamoxifen Neoplasma 39(2): 123-127
Kuralasov, A.K.; Togaĭbaeva, Z.I.; Nurmakova, S.I.; Khan, O.G. 1986: Level of steroid and tropic pituitary hormones in the blood of patients with breast cancer treated with tamoxifen Voprosy Onkologii 32(8): 34-38
Mrugacz, M.łg.; Lebensztejn, D. 2010: Ocular findings in hepatitis C patients treated with interferon Klinika Oczna 112(7-9): 253-256
Bonomi, P.; Gale, M.; Von Roenn, J.; Anderson, K.; Johnson, P.; Wolter, J.; Economou, S. 1988: Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen Seminars in Oncology 15(2 Suppl 1: 26-33
Calzavara-Pinton, P.G.; Carlino, A.; Manfredi, E.; Semeraro, F.; Zane, C.; De Panfilis, G. 1994: Ocular side effects of PUVA-treated patients refusing eye sun protection Acta Dermato-Venereologica. Supplementum 186: 164-165
Chiesa, M.Dalla.; Passalacqua, R.; Michiara, M.; Franciosi, V.; Di Costanzo, F.; Bisagni, G.; Camisa, R.; Buti, S.; Tomasello, G.; Cocconi, G. 2007: Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon alpha-2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial Acta Bio-Medica: Atenei Parmensis 78(3): 204-209
Rykun, V.S.; Soliannikova, O.V.; Ekgardt, V.F.; Kat'kova, E.A. 2001: Changes in the ocular and orbital blood flow in patients with retinal detachment treated surgically Vestnik Oftalmologii 117(5): 25-27
Mustacchi, G.; Milani, S.; Pluchinotta, A.; De Matteis, A.; Rubagotti, A.; Perrota, A. 1994: Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: the G.R.E.T.A. Trial. Group for Research on Endocrine Therapy in the Elderly Anticancer Research 14(5b): 2197-2200
Rinaldi, M.; Della Corte, M.; Ruocco, V.; D'Onofrio, C.; Zanotta, G.; Romano, A. 1993: Ocular involvement correlated with age in patients affected by major and intermedia beta-thalassemia treated or not with desferrioxamine Metabolic Pediatric and Systemic Ophthalmology 16(1-2): 23-25
Neroev, V.V.; Kiseleva, T.N.; Riabina, M.V.; Okhotsimskaia, T.D.; Zolotykh, O.V. 2013: Ocular blood flow assessment in normal subjects and in patients with hyperglycemia based on the results of ultrasonic examination in experiment Vestnik Oftalmologii 129(2): 14-18
Williams, G.M.; Jeffrey, A.M. 1997: Safety assessment of tamoxifen and toremifene Oncology 11(5 Suppl 4: 41-47